| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6af76c32817b3c3fbe7694dd03134f41 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-2462
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-96 |
| filingDate |
2002-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2007-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28a9f22de64e03b5f2bdf7b95119b400
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_537778b1e5ef0fff65d9705879d3c860 |
| publicationDate |
2007-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7229809-B2 |
| titleOfInvention |
Use of modified lysozyme c to prepare medicinal compositions for the treatment of some serious diseases |
| abstract |
A compound of general formula:n n[CH 3 O—(CH 2 —CH 2 —O) n —CH 2 —CH 2 ] x —(NH) y Lysozyme c. (Z) m n nwherein:n y is the number of free amino groups of lysine molecules present in the molecule of lysozyme c; x is comprised between 1 and y; n is comprised between 5 and 1000; Z is a pharmaceutically acceptable acid; m is comprised between 1 and y. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009202516-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009100456-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3037102-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9358274-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11078516-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8728467-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011182873-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011177049-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011171189-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011129454-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9987337-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9931381-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9737591-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8383101-B2 |
| priorityDate |
1998-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |